We are live on
!
Find out more
NTC
North Tide Capital Portfolio holdings
AUM
$469M
1-Year Est. Return
6.57%
This Fund
S&P 500
This Quarter
Est. Return
-1.68%
1 Year Est. Return
+6.57%
3 Year Est. Return
+14.81%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.31B
AUM Growth
-$117M
(-8.2%)
Cap. Flow
-$72.4M
Cap. Flow
% of AUM
-5.52%
Top 10 Holdings %
Top 10 Hldgs %
63.75%
Holding
29
New
3
Increased
6
Reduced
4
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$83.3M |
| 2 |
Viatris
VTRS
|
+$72.9M |
| 3 |
KND
Kindred Healthcare
KND
|
+$38.1M |
| 4 |
GHDX
Genomic Health, Inc.
GHDX
|
+$33.5M |
| 5 |
FRED
Fred's Inc
FRED
|
+$23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$67.2M |
| 2 |
Elevance Health
ELV
|
+$64.6M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$53M |
| 4 |
SVU
SUPERVALU Inc.
SVU
|
+$50.5M |
| 5 |
NUVA
NuVasive, Inc.
NUVA
|
+$49.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 81.84% |
| 2 | Consumer Discretionary | 6.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEM
1
DELISTED
Select Medical
SEM
| $168M | 12.78% |
25,891,200
| – | – |
|
|
2
Teva Pharmaceuticals
TEVA
$37.5B
| $108M | 8.19% |
2,000,000
-1,000,000
| -33% | -$53M |
|
|
3
AbbVie
ABBV
$449B
| $86.6M | 6.6% |
+1,500,000
| New | +$83.3M |
|
|
AMED
4
DELISTED
Amedisys
AMED
| $80.7M | 6.15% |
4,000,000
| – | – |
|
5
Edwards Lifesciences
EW
$50.6B
| $76.6M | 5.84% |
4,500,000
+900,000
| +25% | +$14.2M |
|
|
6
Viatris
VTRS
$20.2B
| $68.2M | 5.2% |
+1,500,000
| New | +$72.9M |
|
7
Bausch Health
BHC
$1.84B
| $65.6M | 5% |
500,000
| – | – |
|
|
KND
8
DELISTED
Kindred Healthcare
KND
| $63M | 4.8% |
3,250,000
+1,750,000
| +117% | +$38.1M |
|
|
TVTY
9
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $61.7M | 4.7% |
3,850,000
| – | – |
|
10
Boston Scientific
BSX
$66.3B
| $59M | 4.5% |
5,000,000
| – | – |
|
11
Orthofix Medical
OFIX
$481M
| $55.7M | 4.25% |
1,800,000
| – | – |
|
|
WW
12
DELISTED
WW International
WW
| $54.9M | 4.18% |
2,000,000
| – | – |
|
|
GHDX
13
DELISTED
Genomic Health, Inc.
GHDX
| $42.5M | 3.23% |
1,500,000
+1,200,000
| +400% | +$33.5M |
|
|
VVUS
14
DELISTED
Vivus Inc
VVUS
| $38.6M | 2.94% |
1,000,000
+100,000
| +11% | +$4.46M |
|
15
Myriad Genetics
MYGN
$585M
| $38.6M | 2.94% |
1,000,000
| – | – |
|
|
GTIV
16
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
| $33.6M | 2.56% |
2,000,000
+1,250,000
| +167% | +$21.9M |
|
17
Quest Diagnostics
DGX
$23.2B
| $30.3M | 2.31% |
500,000
-500,000
| -50% | -$30.8M |
|
|
ELOS
18
DELISTED
Syneron Medical Ltd
ELOS
| $30.1M | 2.29% |
3,000,000
| – | – |
|
|
AFAM
19
DELISTED
Almost Family Inc
AFAM
| $29.6M | 2.26% |
1,090,500
| – | – |
|
|
MNTA
20
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $28.4M | 2.16% |
2,500,000
| – | – |
|
|
MGLN
21
DELISTED
Magellan Health Services, Inc.
MGLN
| $27.4M | 2.08% |
500,000
| – | – |
|
|
SVU
22
DELISTED
SUPERVALU Inc.
SVU
| $26.8M | 2.04% |
428,571
-785,715
| -65% | -$50.5M |
|
|
FRED
23
DELISTED
Fred's Inc
FRED
| $21M | 1.6% |
+1,500,000
| New | +$23M |
|
24
Accuray
ARAY
$31.6M
| $14.5M | 1.11% |
2,000,000
+1,000,000
| +100% | +$8.11M |
|
|
NUVA
25
DELISTED
NuVasive, Inc.
NUVA
| $4.01M | 0.31% |
115,000
-1,385,000
| -92% | -$49.3M |
|
Similar funds
SD
DG
NBC
JWM
JPCCM
MCL
GIIO
FC
North Tide Capital's Q3 2014 Portfolio in Review
As of Q3 2014, North Tide Capital held 29 positions worth $1.31B, down 8.2% from $1.43B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
North Tide Capital withdrew a net $72.4M in Q3 2014, closing 4 positions and reducing 4 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $67.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 82% of assets, down from 82% a quarter earlier, followed by Consumer Discretionary.
Against the trend, North Tide Capital opened a new position in AbbVie worth $86.6M.
- North Tide Capital's largest Q3 2014 buy was AbbVie: 1,500,000 shares worth $86.6M.
- North Tide Capital added most to Kindred Healthcare in Q3 2014, an estimated $38.1M increase.
- North Tide Capital's biggest Q3 2014 reduction was Teva Pharmaceuticals, cutting an estimated $53M.
- North Tide Capital fully exited Wellcare Health Plans, Inc. in Q3 2014, selling an estimated $67.2M.
- North Tide Capital's ten largest holdings make up 64% of its $1.31B portfolio in Q3 2014.
- North Tide Capital opened 3 new positions and closed 4 in Q3 2014.
- North Tide Capital's portfolio value fell 8.2% quarter-over-quarter to $1.31B.
Based on North Tide Capital's 13F filing for Q3 2014, filed 14 Nov 2014.